Chris is a science advisor with a broad range technical expertise including, but not limited to, chemistry, medicinal chemistry, biochemistry, molecular biology, cell biology, and neuroscience. Chris uses this broad range of expertise to assist clients in the preparation and prosecution of patent applications across the biotechnology and life sciences landscape.
Chris has assisted clients in patent application preparation and prosecution of biotechnology and life science patent applications, and has provided his knowledge and insight during due diligence and patentability/freedom to operate landscape analysis.
Chris is a member of the Pittsburgh Intellectual Property Law Association (PIPLA).
Prior to joining Goodwin, Chris was a patent agent at Troutman Pepper. Prior to Troutman Pepper, Chris was a postdoctoral associate at the University of Pittsburgh where he studies the initiation and progression of Parkinson’s disease. Chris earned his PhD in Pharmacy (Medicinal and Natural Products Chemistry) from the University of Iowa, where his research was focused on the design and implementation of high throughput screening campaigns for the discovery and verification of novel anti-cancer therapeutics.
University of Iowa
- U.S. Patent and Trademark Office (USPTO)